SCHEMBL571121

SCHEMBL571121

COc1ccc(-c2coc3cccc(O)c3c2=O)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 8/20 0.72
RAB9A P51151 7/20 0.72
NPC1 O15118 6/20 0.72
MEN1 O00255 6/20 0.72
KMT2A Q03164 6/20 0.72
CYP2C9 P11712 4/20 0.72
CYP2C19 P33261 4/20 0.72
CYP2D6 P10635 3/20 0.72
NFKB1 P19838 3/20 0.72
NFKB2 Q00653 3/20 0.72
RELA Q04206 3/20 0.72
CYP1A2 P05177 2/20 0.72
CYP3A4 P08684 8/20 0.70
ALDH1A1 P00352 7/20 0.70
MAPT P10636 7/20 0.70
TP53 P04637 7/20 0.70
KDM4E B2RXH2 6/20 0.70
HSD17B10 Q99714 5/20 0.70
HPGD P15428 5/20 0.70
MAOA P21397 3/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13267957 0.85 CYP3A4 (0.71) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL18676275 0.84 MAPT (0.68) SMN1; SMN2RAB9ANPC1MEN1KMT2A
4',7-Dimethoxy-5-Hydroxygenistein SCHEMBL572108 0.84 RAB9A (1.00) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL21147057 0.83 MEN1 (0.51) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL30176086 0.83 ABCB1 (0.59) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL4845100 0.83 MAPT (0.68) SMN1; SMN2RAB9ANPC1MEN1KMT2A
Biochanin SCHEMBL29410271 0.83 RAB9A (1.00) SMN1; SMN2RAB9ANPC1MEN1KMT2A
Biochanin SCHEMBL61258 0.83 RAB9A (1.00) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL12892701 0.82 RAB9A (0.81) SMN1; SMN2RAB9ANPC1MEN1KMT2A
Acetic Acid Methyl Ester SCHEMBL28850782 0.82 SMN1; SMN2 (0.56) SMN1; SMN2RAB9ANPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115721671-A Method for extracting and separating effective components of liquorice root in full-industrial-chain cooperation manner 李玉山 2023-03-03 CN disclosed
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2014-08-21 US disclosed
US-8748177-B2 Compositions for proliferation of cells and related methods THE HOSPITAL FOR SICK CHILDREN (CA) 2014-06-10 US disclosed
EP-2598150-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS The Hospital For Sick Children (CA) 2013-06-05 EP disclosed
WO-2012018643-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2012-02-09 WO disclosed
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2011-12-08 US disclosed
WO-2010039679-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 SMN1; SMN2 4188/4885RAB9A 4483/4885NPC1 3331/4885
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 SMN1; SMN2 4188/4885RAB9A 4483/4885NPC1 3331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.